I seem to remember posters here saying the Hospital uptake would be a more difficult barrier and i thought they gave some specific examples of large companies that had not begun to use Enox. I guess that was dismissed today . This guy is very credible unlike a lot of small Bio tech companies who pump at every chance.
i didn't understand the last part of the call... were they discussing differing approaches to characterization of Lovenox? ... i will listen again later.